Relation between cannabis use and subcortical volumes in people at clinical high risk of psychosis

Psychiatry Research - Neuroimaging

Volumn 254, Issue , 2016, Pages 3-9

  Buchy, Lisa ^a   Mathalon, Daniel H ^b   Cannon, Tyrone D ^c   Cadenhead, Kristin S ^d   Cornblatt, Barbara A ^e   McGlashan, Thomas H ^f   Perkins, Diana O ^g   Seidman, Larry J ^h   Tsuang, Ming T ^d   Walker, Elaine F ⁱ   Woods, Scott W ^f   Bearden, Carrie E ^j   Addington, Jean ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c YALE UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e ZUCKER HILLSIDE HOSPITAL   (United States)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^h MASSACHUSETTS GENERAL HOSPITAL   (United States)

ⁱ EMORY UNIVERSITY   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

Amygdala; Hippocampus; Magnetic resonance imaging; Marijuana; Neuroanatomy; Schizophrenia; Thalamus

Indexed keywords

ALCOHOL; CANNABIS;

ADULT; ALCOHOL AND DRUG USE SCALE; ALCOHOL CONSUMPTION; AMYGDALA; ARTICLE; BRAIN REGION; BRAIN SIZE; CANNABIS USE; CONTROLLED STUDY; FEMALE; HIGH RISK POPULATION; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PSYCHOSIS; RATING SCALE; THALAMUS; TOBACCO USE; YOUNG ADULT; ADOLESCENT; PATHOLOGY;

ADOLESCENT; ADULT; AMYGDALA; CANNABIS; FEMALE; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PSYCHOTIC DISORDERS; THALAMUS; YOUNG ADULT;

EID: 84973395010     PISSN: 09254927     EISSN: 18727506     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2016.06.001     Document Type: Article

References (32)

1. Addington J., Cadenhead K.S., Cornblatt B.A., Mathalon D.H., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Woods S.W., Addington J.A., Cannon T.D. North American Prodrome Longitudinal Study (NAPLS 2): overview and recruitment. Schizophr. Res. 2012, 142:77-82.
2. Addington J., Case N., Saleem M.M., Auther A.M., Cornblatt B.A., Cadenhead K.S. Substance use in clinical high risk for psychosis: a review of the literature. Early Interv. Psychiatry 2014, 8:104-112.
3. Arseneault L., Cannon M., Poulton R., Murray R., Caspi A., Moffitt T.E. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ 2002, 325:1212-1213.
4. Bangalore S.S., Prasad K.M., Montrose D.M., Goradia D.D., Diwadkar V.A., Keshavan M.S. Cannabis use and brain structural alterations in first episode schizophrenia--a region of interest, voxel based morphometric study. Schizophr. Res. 2008, 99:1-6.
5. Bora E., Fornito A., Radua J., Walterfang M., Seal M., Wood S.J., Yucel M., Velakoulis D., Pantelis C. Neuroanatomical abnormalities in schizophrenia: a multimodal voxel wise meta-analysis and meta-regression analysis. Schizophr. Res. 2011, 127:46-57.
6. Buchy L., Cadenhead K.S., Cannon T.D., Cornblatt B.A., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Woods S.W., Heinssen R., Bearden C.E., Mathalon D.H., Addington J. Substance use in individuals at clinical high risk of psychosis. Psychol. Med. 2015, 45:2275-2284.
7. Buchy L., Cannon T., Lyngberg K., Cadenhead K., Cornblatt B., McGlashan T., Perkins D., Seidman L., Tsuang M., Walker E., Woods S.W., Bearden C., Mathalon D.H., Addington J. Impact of cannabis use on thalamic connectivity in youth at clinical high risk of psychosis 2015, 251S. Biological Psychiatry, Toronto, ON.
8. Cannon T.D., Sun F., McEwen S.J., Papademetris X., He G., van Erp T.G., Jacobson A., Bearden C.E., Walker E., Hu X., Zhou L., Seidman L.J., Thermenos H.W., Cornblatt B., Olvet D.M., Perkins D., Belger A., Cadenhead K., Tsuang M., Mirzakhanian H., Addington J., Frayne R., Woods S.W., McGlashan T.H., Constable R.T., Qiu M., Mathalon D.H., Thompson P., Toga A.W. Reliability of neuroanatomical measurements in a multisite longitudinal study of youth at risk for psychosis. Hum. Brain Mapp. 2014, 35:2424-2434.
9. Carol E.E., Mittal V.A. Self-reported cannabis use is inconsistent with the results from drug-screening in youth at ultra high-risk for psychosis in Colorado. Schizophr. Res. 2014, 157:317-318.
10. Caspi A., Moffitt T.E., Cannon M., McClay J., Murray R., Harrington H., Taylor A., Arseneault L., Williams B., Braithwaite A., Poulton R., Craig I.W. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene×environment interaction. Biol. Psychiatry 2005, 57:1117-1127.
11. Chan R.C., Di X., McAlonan G.M., Gong Q.Y. Brain anatomical abnormalities in high-risk individuals, first-episode, and chronic schizophrenia: an activation likelihood estimation meta-analysis of illness progression. Schizophr. Bull. 2011, 37:177-188.
12. Drake R.E., Mueser K., McHugo G. Clinical rating scales. Outcomes Assessment in Clinical practice 1996, 113-116. Williams and Wilkins, Baltimore. L. Sederer, B. Dickey (Eds.).
13. Ellison-Wright I., Glahn D.C., Laird A.R., Thelen S.M., Bullmore E. The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis. Am. J. Psychiatry 2008, 165:1015-1023.
14. Fischl B., Salat D.H., Busa E., Albert M., Dieterich M., Haselgrove C., van der Kouwe A., Killiany R., Kennedy D., Klaveness S., Montillo A., Makris N., Rosen B., Dale A.M. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002, 33:341-355.
15. Fusar-Poli P., Bonoldi I., Yung A.R., Borgwardt S., Kempton M.J., Valmaggia L., Barale F., Caverzasi E., McGuire P. Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Arch. Gen. Psychiatry 2012, 69:220-229.
16. Fusar-Poli P., Radua J., McGuire P., Borgwardt S. Neuroanatomical maps of psychosis onset: voxel-wise meta-analysis of antipsychotic-naive VBM studies. Schizophr. Bull. 2012, 38:1297-1307.
17. Glass M., Dragunow M., Faull R.L. Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience 1997, 77:299-318.
18. Habets P., Marcelis M., Gronenschild E., Drukker M., van Os J., Genetic Risk and Outcome of Psychosis Reduced cortical thickness as an outcome of differential sensitivity to environmental risks in schizophrenia. Biol. Psychiatry 2011, 69:487-494.
19. Kuepper R., van Os J., Lieb R., Wittchen H.U., Hofler M., Henquet C. Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study. BMJ 2011, 342:d738.
20. Lorenzetti V., Solowij N., Whittle S., Fornito A., Lubman D.I., Pantelis C., Yucel M. Gross morphological brain changes with chronic, heavy cannabis use. Br. J. Psychiatry 2015, 206:77-78.
21. Mathalon D.H., Pfefferbaum A., Lim K.O., Rosenbloom M.J., Sullivan E.V. Compounded brain volume deficits in schizophrenia-alcoholism comorbidity. Arch. Gen. psychiatry 2003, 60:245-252.
22. McGlashan T.H., Walsh B.C., Woods S.W. The Psychosis Risk Syndrome: Handbook for Diagnosis and Follow-Up 2010, Oxford University Press, New York, NY.
23. Moore T.H., Zammit S., Lingford-Hughes A., Barnes T.R., Jones P.B., Burke M., Lewis G. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007, 370:319-328.
24. Olabi B., Ellison-Wright I., McIntosh A.M., Wood S.J., Bullmore E., Lawrie S.M. Are there progressive brain changes in schizophrenia? A meta-analysis of structural magnetic resonance imaging studies. Biol. Psychiatry 2011, 70:88-96.
25. Pfefferbaum A., Sullivan E.V., Mathalon D.H., Shear P.K., Rosenbloom M.J., Lim K.O. Longitudinal changes in magnetic resonance imaging brain volumes in abstinent and relapsed alcoholics. Alcohol Clin. Exp. Res. 1995, 19:1177-1191.
26. Smith M.J., Cobia D.J., Wang L., Alpert K.I., Cronenwett W.J., Goldman M.B., Mamah D., Barch D.M., Breiter H.C., Csernansky J.G. Cannabis-related working memory deficits and associated subcortical morphological differences in healthy individuals and schizophrenia subjects. Schizophr. Bull. 2014, 40:287-299.
27. Solowij N., Walterfang M., Lubman D.I., Whittle S., Lorenzetti V., Styner M., Velakoulis D., Pantelis C., Yucel M. Alteration to hippocampal shape in cannabis users with and without schizophrenia. Schizophr. Res. 2013, 143:179-184.
28. Valmaggia L.R., Day F.L., Jones C., Bissoli S., Pugh C., Hall D., Bhattacharyya S., Howes O., Stone J., Fusar-Poli P., Byrne M., McGuire P.K. Cannabis use and transition to psychosis in people at ultra-high risk. Psychol. Med. 2014, 44:2503-2512.
29. Welch K.A., McIntosh A.M., Job D.E., Whalley H.C., Moorhead T.W., Hall J., Owens D.G., Lawrie S.M., Johnstone E.C. The impact of substance use on brain structure in people at high risk of developing schizophrenia. Schizophr. Bull. 2011, 37:1066-1076.
30. Welch K.A., Moorhead T.W., McIntosh A.M., Owens D.G., Johnstone E.C., Lawrie S.M. Tensor-based morphometry of cannabis use on brain structure in individuals at elevated genetic risk of schizophrenia. Psychol. Med. 2013, 43:2087-2096.
31. Welch K.A., Stanfield A.C., McIntosh A.M., Whalley H.C., Job D.E., Moorhead T.W., Owens D.G., Lawrie S.M., Johnstone E.C. Impact of cannabis use on thalamic volume in people at familial high risk of schizophrenia. Br. J. Psychiatry 2011, 199:386-390.
32. Yucel M., Solowij N., Respondek C., Whittle S., Fornito A., Pantelis C., Lubman D.I. Regional brain abnormalities associated with long-term heavy cannabis use. Arch. Gen. Psychiatry 2008, 65:694-701.